International Journal of Advanced Nano Computing and Analytics

Exploring Innovations, Sustainability and Future Opportunities in Semiconductor Technologies

Thu, 07 Nov 2024 00:00:00 -0600

Semiconductor technology is the backbone of modern innovations, propelling technological advancements in industries such as electronics, renewable energy, telecommunications, and health-related fields. This review expatiates the fundamental properties and working principles of semiconductor materials that determine device performances, while also tracing the historical trajectory of these technologies from the inception of the transistor to pioneering developments, such as tunnel gate transistors and 2D materials like graphene. Specific challenges such as material constraints, manufacturing complexities, and environmental impacts are highlighted. In response to such challenges, measures for the improvement of sustainability, energy saving, and waste minimization in production are discussed. The research also responds to the extended effects of globalization, including the disruptions like COVID-19 pandemic, on supply chain and emphasizes on the importance of developing resilient production frameworks for future growth. Additionally, this work highlights emerging technologies, including quantum computing, artificial intelligence integration, and nanotechnology, which are poised to redefine data processing and storage. The research vindicates the necessity of innovation and sustainability as the key motivators for enhancing the capabilities of semiconductors and global technology.

Computation Investigation on Doped Graphene for Advanced Electronic Structure: A First-Principles Investigation with Indium and Antimony

Fri, 06 Dec 2024 00:00:00 -0600

This study investigates the impact of Indium (In) and Antimony (Sb) doping on the electronic properties of graphene using Density Functional Theory (DFT) for structure optimization calculations. The doping effect was analyzed with dopant concentrations of 0.72% (two dopant atoms) and 2.88% (eight dopant atoms). The results show that doping graphene with In and Sb produces p-type and n-type semiconductors, respectively. As the quantity of dopants increases, graphene transitions from a semimetal to a semiconductor. Specifically, the band gaps for graphene doped with two and eight atoms of In are 0.5451 eV and 0.1443 eV, while those doped with two and eight atoms of Sb are 1.5684 eV and 0.5726 eV, respectively. These findings highlight the potential for customizing the electronic properties of graphene through doping, making it suitable for various electronic applications.

Precision in Practice: Nanotechnology and Targeted Therapies for Personalized Care

Ashutosh Sengar — Mon, 30 Dec 2024 02:36:22 -0600

Customization of medicine has made healthcare even more personalized, enhancing therapeutical efficiency with low adverse effects. It can be achieved through an innovative tool that has reached unprecedented abilities through the process of nanotechnology in targeted drug delivery, advanced diagnostics, and therapeutic systems. This makes a review on the integration of nanotechnology with personalized medicine-including historical considerations towards applications in today's contexts up to future perspectives.

The targeting of diseased tissues has proven to be tremendous, considering a combination of both passive and active targeting mechanisms that nanospheres assume the form of liposomes, dendrimers, or polymeric micelles. Quantum dots and nanosensors have revolutionized the area of diagnostics, enabling detection at an earliest possible stage with real-time monitoring, changing patient care forever. Theranostic platforms, integrating therapeutic agents with diagnostic tools, really reveal the dynamic ability to customize treatments.

Despite these strides forward, the critical problems to be overcome are those related to biological complexity, barriers caused by regulation, and eventual long-term toxicities. Biocompatible biodegradable nanocarrier research and responsive system explorations will help move such applications forward in a positive fashion toward better and safer designs. The joining of wearable nanotechnology to a nanoparticle-enabled gene delivery system is probably going to move standards of care.

This review outlines the crucial role nanotechnology is playing in moving personalized medicine forward, from bridging diagnosis to therapy and filling the gap of heterogeneity in disease. But a lot more is to come because it holds promise for a revolution in healthcare ever more precise, adaptable, and patient-centered with innovation and interdisciplinary collaboration continuing.

Nanoparticles in Cancer Therapy: Current Progress, Challenges, and Future Perspectives in Clinical Translation

Raghavendra Sashi Krishna Nagampalli, Eswar Kumar Nadendla — Mon, 30 Dec 2024 00:00:00 -0600

Cancer treatment is evolving with the advent of nanotechnology, shifting from conventional therapies to precision medicine. Nanoparticles (1–100 nm) which encapsulate drugs and direct them to tumor sites offer unique advantages in cancer therapy, including enhanced drug delivery, reduced toxicity, and improved specificity. This editorial examines various types of nanoparticles, with focus on those that have progressed to clinical trials, while addresses the challenges in translating these innovations from the laboratory to clinical practice. Despite the growing body of researNanoparticlesch, the number of approved nanodrugs remains limited. Hence a deeper understanding of nano formulations and their targeting mechanisms will be crucial to advancing cancer treatment in the future.

Nanotechnology : Challenges and Applications in Nano Medicine

S P Subala — Tue, 31 Dec 2024 00:00:00 -0600

In recent years, nanotechnology—a synthesisof various scientific and technological fields—has advanced significantly and is seen to becrucial to the transformation of the health careindustry. It has the potential to revolutionizea number of illnesses and conditions, tailoredmedication delivery, drug research, anddiscovery.